ORBIMED ADVISORS LLC 13D and 13G filings for Xtant Medical Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-14 7:09 pm Sale | 2025-04-10 | 13D | Xtant Medical Holdings, Inc. XTNT | ORBIMED ADVISORS LLC | 0 0.000% | -73,114,592 (Position Closed) | Filing |
| 2024-09-10 4:12 pm Unchanged | 2024-09-03 | 13D | Xtant Medical Holdings, Inc. XTNT | ORBIMED ADVISORS LLC | 73,114,592 52.700% | 0 (Unchanged) | Filing |
| 2023-08-03 4:59 pm Unchanged | 2023-08-01 | 13D | Xtant Medical Holdings, Inc. XTNT | ORBIMED ADVISORS LLC | 73,114,592 56.700% | 0 (Unchanged) | Filing |
| 2023-05-05 11:14 am Unchanged | 2023-05-01 | 13D | Xtant Medical Holdings, Inc. XTNT | ORBIMED ADVISORS LLC | 73,114,592 67.100% | 0 (Unchanged) | Filing |
| 2022-08-30 4:37 pm Purchase | 2022-08-26 | 13D | Xtant Medical Holdings, Inc. XTNT | ORBIMED ADVISORS LLC | 73,114,592 67.900% | 241,098 (+0.33%) | Filing |
| 2021-04-09 4:36 pm Purchase | 2021-04-06 | 13D | Xtant Medical Holdings, Inc. XTNT | ORBIMED ADVISORS LLC | 72,873,494 84.000% | 70,422 (+0.10%) | Filing |